QRONS INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-14: Form 8-K; Period of report 2026-08-14; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2026-04-06: Form 8-K; Period of report 2026-04-06; Description 7.01 Regulation FD Disclosure.
- 2025-12-19: Form 8-K; Period of report 2025-12-19; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2025-07-10: Form 8-K; Period of report 2025-07-10; Description 7.01 Regulation FD Disclosure.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2026-08-14 | 8-K | 2026-08-14 | 2.02 Results of Operations and Financial Condition | 2.02 On August 14, 2026, Qrons Inc. (the “Company”) issued a shareholder update containing preliminary, unaudited operating information regarding the three months ended June 30, 2026 and certain subsequent July 2026 operating indicators. | qron_8k.htm |
| 2026-04-06 | 8-K | 2026-04-06 | 7.01 Regulation FD Disclosure | qron_8k.htm | |
| 2025-12-19 | 8-K | 2025-12-19 | 7.01 Regulation FD Disclosure | 7.01 To begin, I want to acknowledge that management recognizes the frustration many shareholders are feeling with the progress of First Person in fiscal 2025. | qron_8k.htm |
| 2025-07-10 | 8-K | 2025-07-10 | 7.01 Regulation FD Disclosure | qron_8k.htm | |
| 2025-04-01 | 8-K | 2025-03-29 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Former Independent Registered Public Accounting Firm. | qron_8k.htm |
| 2025-03-26 | 8-K | 2025-03-12 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Former Independent Registered Public Accounting Firm. | qron_8k.htm |
| 2025-02-05 | 8-K | 2025-01-31 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 2.01 As disclosed in the Current Report on Form 8-K of the Company filed on January 21, 2025 (the “January 21 Current Report”), on January 15, 2025, the Company entered into a Plan and Agreement of Merger (the “Merger Agreement”) with First Person Ltd., an Alberta, Canada, corporation (“First Person”), pursuant to which a wholly-owned subsidiary (the “Merger Sub”) of the Company would merge (the “FP Merger”) with and into First Person, with First Person becoming a wholly-owned subsidiary of the Company, as a result of the FP Merger. 3.02 The description of the issuances of Series B Convertible Preferred Stock to First Person’s pre-merger shareholders set forth in Item 2.01 above is incorporated by reference into this Item 3.02. 5.01 In conjunction with the Merger Agreement, pursuant to a stock purchase agreement (the “Control SPA”) Jonah Meer and Ido Merfeld each sold 1,000 shares of the Company’s Series A Preferred Stock to Cory J. Rosenberg, for $10.00 and other good and valuable consideration. 5.02 On January 31, 2025, there occurred a change in control of the Company, in conjunction with the acquisition of First Person Ltd. (First Person), as well as a change the Company’s Board of Directors and the Company’s executive officers. | qron_8k.htm |
| 2025-01-21 | 8-K | 2025-01-15 | 1.01 Entry into a Material Definitive Agreement; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 Entry into a Material Definitive Agreement. 5.03 On January 2, 2025, the Company filed with the State of Wyoming an Articles of Amendment to its Articles of Incorporation (the “Articles of Amendment”), which (a) restated the Certificate of Designation of the Company’s Series A Preferred Stock, as summarized below, and (b) established a Series B Convertible Preferred Stock with the rights, preferences, powers, restrictions and limitations, as summarized below. | qron_8k.htm |
| 2024-10-22 | 8-K | 2024-10-16 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 The information contained in Item 1.01 above is incorporated herein by reference in this Item 3.02. | qron_8k.htm |
| 2023-11-06 | 8-K | 2023-11-02 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On September 8, 2023, Qrons, Inc..(the “Company”) was informed that Pinnacle Accountancy Group of Utah a dba of Heaton & Company, PLLC (“Pinnacle”) had sold a portion of its public company business to GreenGrowth CPAs (“GreenGrowth”). | qron_8k.htm |
| 2023-07-24 | 8-K | 2023-05-30 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 On July 17, 2023 Qrons Inc. (the “Company”) entered into a License Agreement Term Sheet (the “Agreement”) with Professors Benjamin Sredni and Michael Albeck (the “Professors”) and Dr. Ido Merfeld (“Merfeld”), the Company’s President and co-Founder. 1.02 On May 30, 2023, Dartmouth Office of Entrepreneurship and Technology Transfer (“Dartmouth”) issued to Qrons a Notice of Default that Qrons had materially breached its license obligations under a license agreement that was effective September 3, 2019. 2.03 The information contained in Item 1.01 above is incorporated by reference in this Item 2.03. 3.02 The information contained in Item 1.01 above is incorporated herein by reference in this Item 3.02. 7.01 On July 20, 2023, the Company issued a press release disclosing the entry into the License Agreement Term Sheet as more fully described above in Item 1.01 herein. | qron_8k.htm |
| 2021-06-21 | 8-K | 2021-06-15 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 On June 15, 2021, Qrons Inc. (the “Company”) entered into a note purchase agreement with Quick Capital, LLC, a Wyoming limited liability company (“Quick Capital”), pursuant to which the Company issued Quick Capital a twelve-month convertible promissory note in the principal amount of $115,000 (the “Note”) for a $100,000 investment, which included an original issuance discount of 10% and a $3,500 credit for Quick Capital’s legal and transaction costs. 2.03 The information contained in Item 1.01 above is incorporated by reference in this Item 2.03. 3.02 The information contained in Item 1.01 above is incorporated herein by reference in this Item 3.02. | form8k.htm |
| 2019-12-20 | 8-K | 2019-12-17 | 3.02 Unregistered Sales of Equity Securities | 3.02 On December 17, 2019, Qrons Inc. (the “Company”) granted a five-year immediately exercisable option to purchase 325,000 shares of its common stock at an exercise price of $2.00 per share, to each of Jonah Meer, its Chief Executive Officer, and Ido Merfeld, its President, for services provided to the Company. | form8k.htm |
| 2019-12-03 | 8-K | 2019-11-30 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On November 30, 2019, Qrons Inc. (the “Company”) entered into a royalty and license fee sharing agreement (the “Royalty Agreement”) with Ariel Scientific Innovations Ltd., an Israeli corporation (“Ariel”) which, among other things, supersedes and terminates the license and research funding agreement, dated December 14, 2016, as amended (the “License Agreement”), between the parties. 5.02 Dr. John N. Bonfiglio was terminated as Chief Operating Officer of the Company as of November 30, 2019. | form8k.htm |
| 2019-11-06 | 8-K | 2019-11-04 | 1.01 Entry into a Material Definitive Agreement | 1.01 As described in the Current Report on Form 8-K of Qrons Inc. (the “Company”) filed with the SEC on July 18, 2018, the Company entered into a one-year sponsored research agreement (the "Sponsored Research Agreement") with the Trustees of Dartmouth College ("Dartmouth") pursuant to which the Company will support and fund the cost of research conducted by Dartmouth of mutual interest to the parties in accordance with the Agreement. | form8k.htm |
| 2019-10-08 | 8-K | 2019-10-02 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 2, 2019, Qrons Inc. (the “Company”) entered into an Intellectual Property License Agreement (the “Agreement”) with the Trustees of Dartmouth College (“Dartmouth”) pursuant to which, effective September 3, 2019 (the Effective Date”), Dartmouth granted the Company an exclusive world-wide license under the patent application entitled “Mechanically Interlocked Molecules-based Materials for 3D Printing” in the field of human and animal health and certain additional patent rights to use and commercialize licensed products and services. | form8k.htm |
| 2019-08-12 | 8-K | 2019-08-08 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 On August 8, 2019, the Company entered into a six-month services agreement with PCG Advisory, Inc. ("PCG") under which PCG will provide investor relations and capital market advisory services to the Company. 3.02 The information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. 8.01 On August 12, 2019, the Company issued a press release announcing the commencement of trading of its common stock on the OTCQB Venture Market on August 12, 2019, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. | form8k.htm |
| 2019-06-27 | 8-K | 2019-06-25 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 On June 25, 2019, Qrons Inc. (the "Company") entered into a term sheet ("Term Sheet") with John N. Bonfiglio, PhD ("Bonfiglio") pursuant to which Dr. Bonfiglio will serve as the Company's chief operating officer, effective July 1, 2019. 5.02 As described in Item 1.01 above, Dr. Bonfiglio was appointed as Chief Operating Officer of the Company, effective July 1, 2019, to serve in such office at the pleasure of the board of directors. 8.01 On June 27, 2019, the Company issued a press release announcing the appointment of Dr. Bonfiglio as Chief Operating Officer of the Company. | form8k.htm |
| 2019-05-03 | 8-K | 2019-05-01 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 On May 1, 2019, Qrons Inc. (the "Company") issued a promissory note (the "Note") to CubeSquare, LLC, a Delaware limited liability company ("CubeSquare"), in the principal amount of $50,000. 2.03 The disclosure set forth under Item 1.01 (Entry into a Material Definitive Agreement) above is incorporated by reference into this Item 2.03. 3.02 The disclosure set forth above under Item 1.01 (Entry into a Material Definitive Agreement) above is incorporated by reference into this Item 3.02. | form8k.htm |
| 2019-04-16 | 8-K | 2019-04-11 | 1.01 Entry into a Material Definitive Agreement | 1.01 On April 11, 2019, Qrons Inc. (the "Company") amended its services agreement (the "First Amendment") with Ariel Scientific Innovations Ltd. ("Ariel") entered into on March 6, 2018, to extend the term thereof for an additional twelve months until March 6, 2020. | form8k.htm |
| 2018-12-14 | 8-K | 2018-12-10 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On December 12, 2018, Qrons Inc. (the "Company") further amended (the "Second Amendment") its service agreement, dated December 14, 2017 with Ariel Scientific Innovations Ltd., (the "Services Agreement") to extend the term thereof for an additional twelve-month period until December 14, 2019. 3.02 On December 10, 2018, the Company awarded Liat Hammer an immediately exercisable five-year option to purchase an aggregate of 145,000 shares of common stock at an exercise price of $2.00 per share in consideration for science advisory services provided to the Company. | form8k.htm |
| 2018-07-18 | 8-K | 2018-07-12 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On July 12, 2018, Qrons Inc. (the "Company") entered into a one-year sponsored research agreement (the "Sponsored Research Agreement"), with the Trustees of Dartmouth College ("Dartmouth") pursuant to which the Company will support and fund the cost of research conducted by Dartmouth of mutual interest to the parties in accordance with the Agreement. 8.01 On July 18, 2018, the Company issued a press release announcing the signing of the Sponsored Research Agreement with Dartmouth. | form8k.htm |
| 2018-04-20 | 8-K | 2018-04-16 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On April 16, 2018, Qrons Inc. (the "Company") entered into a one-year advisory board member consulting agreement ("Advisory Board Agreement") with Chenfeng Ke, pursuant to which he will serve on the Company's Scientific Advisory Board. 8.01 On April 20, 2018, the Company issued a press release announcing the appointment of Chenfeng Ke to the Company's Scientific Advisory Board. | form8k.htm |
| 2018-04-16 | 8-K | 2018-04-12 | 1.01 Entry into a Material Definitive Agreement | 1.01 On April 12, 2018, Qrons Inc. (the "Company") amended its services agreement, dated December 12, 2017 (the "Amendment") with Ariel Scientific Innovations Ltd., which services agreement was filed with the Company's Current Report on Form 8-K on December 15, 2017 (the "Services Agreement"). | form8k.htm |
| 2018-03-26 | 8-K | 2018-03-26 | 8.01 Other Events | 8.01 On March 26, 2018, Qrons Inc. issued a press release announcing the exercise of its option under an agreement with the Trustees of Dartmouth (as previously filed with its Current Report on Form 8-K filed with the SEC on October 20, 2017) to negotiate a worldwide, exclusive definitive license agreement for certain intellectual property covered under such agreement. | form8k.htm |
| 2018-02-12 | 8-K | 2018-02-12 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Qrons Inc. (the "Company") sold 312,500 shares of its common stock to Conventus Holdings SA, a BVI corporation ("Conventus") and raised $500,000 pursuant to a subscription agreement, dated January 23, 2018 (the "Subscription Agreement"), in a private placement offering pursuant to an exemption from registration under Regulation S of the Securities Act of 1933, as amended ("Reg S"). 8.01 On February 12, 2018, the Company issued a press release announcing the closing of the private placement offering and the appointment of Pavel Hillman to the Company's Advisory Board. | form8k.htm |
| 2017-12-15 | 8-K | 2017-12-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 Qrons Inc. (the "Company") and Ariel Scientific Innovations Ltd., formerly known as Ariel University R&D Co., Ltd. ("Ariel"), entered into Addendum #1, effective December 13, 2017 (the "Addendum") to the License and Research Funding Agreement entered into by them on December 14, 2016 (the "License Agreement") pursuant to which Ariel was permitted to exercise a portion of the warrant granted pursuant to Section 7.3 of the License Agreement. | form8k.htm |
| 2017-11-21 | 8-K | 2017-11-15 | 8.01 Other Events | 8.01 As reported by Qrons Inc. (the "Company") in its Current Report on Form 8-K filed with the SEC on October 20, 2017, the Company agreed to finance the prosecution of patents by Dartmouth College ("Dartmouth") to protect its intellectual property pursuant to an option agreement with Dartmouth. | form8k.htm |
| 2017-10-20 | 8-K | 2017-10-18 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 On October 17, 2017, Qrons Inc. (the "Company") entered into an option agreement (the "Option Agreement") with the Trustees of Dartmouth College ("Dartmouth"), which provides for, among other things, the grant to the Company of a one-year exclusive option to negotiate a worldwide, royalty bearing, exclusive license with Dartmouth for 3D printable materials in the field of human and animal health. 8.01 On October 20, 2017, Qrons Inc. issued a press release announcing the signing of an option agreement with Dartmouth. | form8k.htm |
| 2017-10-11 | 8-K | 2017-10-10 | 8.01 Other Events | 8.01 On October 10, 2017, Qrons Inc. issued a press release announcing the launch of its website www.qrons.com. | form8k.htm |
| 2017-08-11 | 8-K | 2017-08-08 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.03 On July 6, 2017, the board of directors and shareholders of Qrons Inc. (the "Company") approved an amendment to the Company's Articles of Incorporation changing the name of the Company from "BioLabMart Inc." to "Qrons Inc.", as described in the Company's Schedule 14C Information Statement filed with the SEC on July 18, 2017. 8.01 On August 11, 2017, the Company issued a press release announcing the name change. | form8k.htm |
| 2017-07-06 | 8-K | 2017-07-06 | 8.01 Other Events | 8.01 The common stock of BioLabMart Inc. was approved by the Financial Industry Regulatory Authority for quotation on the OTC pink sheets under the symbol "BLMB" as of July 3, 2017. | form8k.htm |